Found 7 matching trials
Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2 PHASE1 Infection with dengue viruses is the leading cause of hospitalization and d...
Show More Location
Center for Immunization Research (CIR), Johns Hopkins School of Public Health
Learn More & Join Trial
Safety, Virological and Immunological Assessment of Live Attenuated Dengue Serotype 2 rDEN2delta30-7169. EARLY_PHASE1 Dengue viral infection and dengue hemorrhagic fever (DHF) are important eme...
Show More Learn More & Join Trial
Dengue Controlled Human Infection Model in Dhaka, Bangladesh PHASE2 The primary objective is to determine, among dengue-naïve adults in an ende...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune) EARLY_PHASE1 rDEN2Δ30-7169 is a dengue challenge strain that previously reports its vire...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults PHASE1 Dengue viruses can cause dengue fever and other more serious illnesses. The...
Show More Location
John Hopkins Bloomberg School of Public Health - Center for Immunization Research (CIR)
Learn More & Join Trial
Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults PHASE1 Dengue viruses infect millions of people throughout the tropics and subtrop...
Show More Location
Center for Immunization Research, Johns Hopkins School of Public Health
Learn More & Join Trial
Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge PHASE1 The purpose of this study is to evaluate the ability of a single dose of a ...
Show More Location
Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health
Learn More & Join Trial